Intrinsic Value

The intrinsic value of Akso Health Group (8HX) under the Base Case is 0.07 EUR per share. Compared with the current market price of 1.09 EUR, the stock appears Overvalued by 94% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

8HX Intrinsic Value
€0.07
Overvaluation 94%
Intrinsic Value
Price €1.09
Alert me when 8HX is below its intrinsic value
Today €0.05 · 95.2% below the current price

8HX is valued in line with its history. A premium of this size has been typical over the past 5 years.

Alternatives to 8HX

Fundamental Analysis

What Akso Health Group Does

Health Care

Akso Health Group is a China-based healthcare company that sells health-related products and also provides medical and wellness services. In plain terms, it sits between suppliers and end users: it sources products such as medical devices, consumable healthcare items, and other wellness goods, then sells them through its own channels and business partners.

Headquarters
China CN
Employees
27
IPO date
Nov 3, 2017
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Past 12 months

Continue 8HX Research

Decided on Akso Health Group? Get an email when 8HX reaches the price you’d buy at. Free with an account.

Other Akso Health Group listings

What is the Intrinsic Value of one 8HX stock?

The intrinsic value for Akso Health Group (8HX) under the Base Case is 0.07 EUR.

Is 8HX stock undervalued or overvalued?

Compared with the current market price of 1.09 EUR, the stock appears Overvalued by 94% .

How reliable are our estimates? See how past valuations played out
Back to Top